Mode
Text Size
Log in / Sign up
N/A Completed N=354 Treatment

Triathlon® Posteriorly Stabilized (PS) Total Knee System - Outcomes Study

Arthroplasty, Replacement, Knee
Source: ClinicalTrials.gov NCT00957021 ↗
Enrolled (actual)
354
Serious AEs
24.3%
Results posted
Dec 2013
Primary outcomePrimary: Range of Motion — 124 degrees

Summary

The purpose of this study is to evaluate the clinical outcomes (range of motion, pain, function, radiographic stability, and health related quality of life) of patients receiving the Triathlon® Posterior Stabilized (PS) Total Knee System. These outcomes will be evaluated using pre-operative scores and comparing them to post-operative scores in addition to being compared with cases who received the Scorpio® PS implant.

Outcome Measures

OutcomeResultp-value
PRIMARY
Range of Motion
124 —
SECONDARY
Patient Outcome Knee Society Score
93.77; 57.36; 86.26; 30.99; 93.96; 57.76 <.0001 sig
SECONDARY
Patient Outcome SF-36
48.16; 15.32; 55.21; 2.58; 47.34; 14.54 <.0001 sig
SECONDARY
Patient Outcome WOMAC
45.11 —
SECONDARY
Patient Outcome Lower-Extremity Activity Scale
11.22; 1.97; 11.04; 1.86; 11.15; 1.95 <.0001 sig
SECONDARY
Radiographic Outcome
1; 2; 3 —

Eligibility Criteria

Inclusion Criteria

  • The subject is a male or non-pregnant female 21-80 years of age at the time of enrollment.
  • The subject requires a primary cemented total knee replacement.
  • The subject has a diagnosis of osteoarthritis (OA), traumatic arthritis (TA), or avascular necrosis (AVN).
  • The subject has intact collateral ligaments.
  • The subject has signed the IRB approved, study specific Informed Patient Consent Form.
  • The subject is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.

Exclusion Criteria

  • The subject has inflammatory arthritis.
  • The subject is morbidly obese, BMI > 40.
  • The subject has a history of total or unicompartmental reconstruction of the affected joint.
  • The subject has had a high tibial osteotomy or femoral osteotomy.
  • The subject has a neuromuscular or neurosensory deficiency that would limit the ability to assess the performance of the device.
  • The subject has a systemic or metabolic disorder leading to progressive bone deterioration.
  • The subject is immunologically suppressed, or receiving chronic steroids (>30 days duration).
  • The subject's bone stock is compromised by disease or infection and cannot provide adequate support and/or fixation to the prosthesis.
  • The subject has had a knee fusion at the affected joint.
  • The subject has an active or suspected latent infection in or about the knee joint.
  • The subject is a prisoner.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00957021). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search